Comparative tolerability of therapies for cytomegalovirus retinitis (Q33733029)

29 July 2017

1 reference

title

Comparative tolerability of therapies for cytomegalovirus retinitis (English)

1 reference

cytomegalovirus retinitis

29 July 2017

0 references

1 reference

A Tseng

2

0 references

Sharon Walmsley

1 reference

ORCID Public Data File 2021

author name string

S Walmsley

series ordinal

1

1 reference

29 July 2017

publication date

1 September 1999

1 reference

29 July 2017

1 reference

29 July 2017

volume

21

1 reference

29 July 2017

issue

3

1 reference

29 July 2017

page(s)

203-224

1 reference

Combined short- and long-term therapy for the treatment of cytomegalovirus retinitis using ganciclovir (BW B759U)

29 July 2017

cites work

1 reference

12 December 2020

Infections caused by central venous catheters in patients with acquired immunodeficiency syndrome

1 reference

12 December 2020

Intravitreal foscarnet for cytomegalovirus retinitis in a patient with acquired immunodeficiency syndrome

1 reference

12 December 2020

Increasing survival in AIDS patients with cytomegalovirus retinitis treated with combination antiretroviral therapy including HIV protease inhibitors

1 reference

12 December 2020

Foscarnet. A review of its antiviral activity, pharmacokinetic properties and therapeutic use in immunocompromised patients with cytomegalovirus retinitis

1 reference

12 December 2020

Decline in deaths from AIDS due to new antiretrovirals

1 reference

12 December 2020

Use of the ganciclovir implant for the treatment of cytomegalovirus retinitis in the era of potent antiretroviral therapy: recommendations of the International AIDS Society-USA panel

1 reference

12 December 2020

Effect of 9-(1,3-dihydroxy-2-propoxymethyl) guanine on serious cytomegalovirus disease in eight immunosuppressed homosexual men

1 reference

12 December 2020

The use of oral ganciclovir in the treatment of cytomegalovirus retinitis in patients with AIDS.

1 reference

12 December 2020

Adverse events and autopsy findings after intravitreous cidofovir (HPMPC) therapy in patients with acquired immune deficiency syndrome (AIDS).

1 reference

12 December 2020

Treatment of cytomegalovirus retinitis with intravitreous cidofovir in patients with AIDS. A preliminary report

1 reference

12 December 2020

Intravitreal ganciclovir for cytomegalovirus retinitis in AIDS patients

1 reference

12 December 2020

Combination ganciclovir and foscarnet in the treatment of clinically resistant cytomegalovirus retinitis in patients with acquired immunodeficiency syndrome

1 reference

12 December 2020

Long-term intravitreal ganciclovir therapy for cytomegalovirus retinopathy

1 reference

12 December 2020

Ganciclovir treatment of life- or sight-threatening cytomegalovirus infection: experience in 314 immunocompromised patients

1 reference

12 December 2020

A randomized, controlled study of intravenous ganciclovir therapy for cytomegalovirus peripheral retinitis in patients with AIDS. AIDS Clinical Trials Group and Cytomegalovirus Cooperative Study Group

1 reference

12 December 2020

Long-lasting remission of cytomegalovirus retinitis without maintenance therapy in human immunodeficiency virus-infected patients.

1 reference

12 December 2020

Synergistic effect of ganciclovir and foscarnet on cytomegalovirus replication in vitro

1 reference

12 December 2020

The role of ganciclovir for the management of cytomegalovirus retinitis in HIV patients: Pharmacological review and update on new developments

1 reference

12 December 2020

Oral ganciclovir for patients with cytomegalovirus retinitis treated with a ganciclovir implant. Roche Ganciclovir Study Group

1 reference

12 December 2020

(S)-1-[3-hydroxy-2-(phosphonylmethoxy)propyl]cytosine (cidofovir): results of a phase I/II study of a novel antiviral nucleotide analogue

1 reference

12 December 2020

Management of drug interactions in patients with HIV.

1 reference

12 December 2020

Iritis and hypotony after treatment with intravenous cidofovir for cytomegalovirus retinitis

1 reference

12 December 2020

Phase I/II study of intravitreal cidofovir for the treatment of cytomegalovirus retinitis in patients with the acquired immunodeficiency syndrome

1 reference

12 December 2020

A dose-ranging study of daily maintenance intravenous foscarnet therapy for cytomegalovirus retinitis in AIDS.

1 reference

12 December 2020

Phase II dose-ranging trial of foscarnet salvage therapy for cytomegalovirus retinitis in AIDS patients intolerant of or resistant to ganciclovir (ACTG protocol 093). AIDS Clinical Trials Group of the National Institute of Allergy and Infectious Dis

1 reference

12 December 2020

Treatment of cytomegalovirus retinitis with an intraocular sustained-release ganciclovir implant. A randomized controlled clinical trial.

1 reference

12 December 2020

Changing incidence of AIDS-defining illnesses in the era of antiretroviral combination therapy

1 reference

12 December 2020

Cytomegalovirus retinitis after initiation of highly active antiretroviral therapy

1 reference

12 December 2020

Once-weekly intraocular injections of ganciclovir for maintenance therapy of cytomegalovirus retinitis: clinical and ocular outcome

1 reference

12 December 2020

Treatment of cytomegalovirus retinitis with ganciclovir

1 reference

12 December 2020

Combination foscarnet and ganciclovir therapy vs monotherapy for the treatment of relapsed cytomegalovirus retinitis in patients with AIDS. The Cytomegalovirus Retreatment Trial. The Studies of Ocular Complications of AIDS Research Group in Collabor

1 reference

12 December 2020

Experience with a totally implantable venous access device (Port-A-Cath) in patients with AIDS.

1 reference

12 December 2020

High dose intravitreal foscarnet in the treatment of cytomegalovirus retinitis in AIDS.

1 reference

12 December 2020

Combination of ganciclovir and granulocyte-macrophage colony-stimulating factor in the treatment of cytomegalovirus retinitis in AIDS patients. The ACTG 073 Team

1 reference

12 December 2020

Therapeutic effect of combination antiretroviral therapy on cytomegalovirus retinitis

1 reference

12 December 2020

Intravitreal ganciclovir in the treatment of AIDS-associated cytomegalovirus retinitis

1 reference

12 December 2020

Treatment of cytomegalovirus retinitis with dihydroxy propoxymethyl guanine

1 reference

12 December 2020

Prevention of foscarnet nephrotoxicity

1 reference

12 December 2020

Recurrent iritis after intravenous administration of cidofovir

1 reference

12 December 2020

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

1 reference

12 December 2020

Genital and oral erosions induced by foscarnet

1 reference

12 December 2020

Anterior nongranulomatous uveitis after intravitreal HPMPC (cidofovir) for the treatment of cytomegalovirus retinitis. Analysis and prevention.

1 reference

12 December 2020

Infections associated with Hickman catheters in patients with acquired immunodeficiency syndrome

1 reference

12 December 2020

Initial experience with an eight-month sustained-release intravitreal ganciclovir implant for the treatment of CMV retinitis associated with AIDS.

1 reference

12 December 2020

Oral ganciclovir for cytomegalovirus retinitis in patients with AIDS: results of two randomized studies

1 reference

12 December 2020

Treatment of cytomegalovirus retinitis with trisodium phosphonoformate hexahydrate (Foscarnet)

1 reference

12 December 2020

Effect of the human immunodeficiency virus epidemic on mortality from opportunistic infections in the United States in 1993.

1 reference

12 December 2020

Infections associated with totally implantable venous access devices (TIVAD) in human immunodeficiency virus-infected patients

1 reference

12 December 2020

Treatment of cytomegalovirus retinopathy in patients with acquired immunodeficiency syndrome. Use of the experimental drug 9-[2-hydroxy-1-(hydroxymethyl)ethoxymethyl]guanine

1 reference

12 December 2020

Oral ganciclovir as maintenance treatment for cytomegalovirus retinitis in patients with AIDS. Syntex Cooperative Oral Ganciclovir Study Group

1 reference

12 December 2020

Morbidity and toxic effects associated with ganciclovir or foscarnet therapy in a randomized cytomegalovirus retinitis trial. Studies of ocular complications of AIDS Research Group, in collaboration with the AIDS Clinical Trials Group

1 reference

12 December 2020

Increased survival of a cohort of patients with acquired immunodeficiency syndrome and cytomegalovirus retinitis who received sodium phosphonoformate (foscarnet).

1 reference

12 December 2020

Restoration of cytomegalovirus-specific CD4+ T-lymphocyte responses after ganciclovir and highly active antiretroviral therapy in individuals infected with HIV-1

1 reference

12 December 2020

Intravenous cidofovir for peripheral cytomegalovirus retinitis in patients with AIDS. A randomized, controlled trial

1 reference

12 December 2020

Evaluation of retinal toxicity and efficacy of anti-cytomegalovirus and anti-herpes simplex virus antiviral phosphorothioate oligonucleotides ISIS 2922 and ISIS 4015.

1 reference

12 December 2020

Relationship between foscarnet exposure, baseline cytomegalovirus (CMV) blood culture and the time to progression of CMV retinitis in HIV-positive patients

1 reference

12 December 2020

Lack of reactivation of cytomegalovirus (CMV) retinitis after stopping CMV maintenance therapy in AIDS patients with sustained elevations in CD4 T cells in response to highly active antiretroviral therapy

1 reference

12 December 2020

Pre-treatment with hydration and electrolytes may prevent dose limiting toxicities during foscarnet induction therapy.

1 reference

12 December 2020

Treatment of cytomegalovirus retinitis with intravitreal ganciclovir. Long-term results

1 reference

12 December 2020

Intravitreous and plasma concentrations of ganciclovir and foscarnet after intravenous therapy in patients with AIDS and cytomegalovirus retinitis.

1 reference

12 December 2020

Impact of protease inhibitors on AIDS-defining events and hospitalizations in 10 French AIDS reference centres. Fédération National des Centres de Lutte contre le SIDA

1 reference

12 December 2020

Antisense-oligonucleotide therapy

1 reference

12 December 2020

Macrophage-active colony-stimulating factors enhance human immunodeficiency virus type 1 infection in bone marrow stem cells

1 reference

12 December 2020

Penile ulceration with foscarnet therapy

1 reference

12 December 2020

Retinal and gastrointestinal disease due to cytomegalovirus in patients with the acquired immune deficiency syndrome: prevalence, natural history, and response to ganciclovir therapy

1 reference

12 December 2020

Foscarnet induction therapy for cytomegalovirus retinitis in AIDS: comparison of twice-daily and three-times-daily regimens

1 reference

12 December 2020

An economic evaluation of oral compared with intravenous ganciclovir for maintenance treatment of newly diagnosed cytomegalovirus retinitis in AIDS patients

1 reference

12 December 2020

Ganciclovir for the treatment and suppression of serious infections caused by cytomegalovirus

1 reference

12 December 2020

Control of cytomegalovirus retinitis using sustained release of intraocular ganciclovir

1 reference

12 December 2020

Subcutaneous recombinant granulocyte-macrophage colony-stimulating factor used as a single agent and in an alternating regimen with azidothymidine in leukopenic patients with severe human immunodeficiency virus infection.

1 reference

12 December 2020

Treatment of serious cytomegalovirus infections with 9-(1,3-dihydroxy-2-propoxymethyl)guanine in patients with AIDS and other immunodeficiencies

1 reference

12 December 2020

Efficacy of intravitreal foscarnet in a patient with AIDS

1 reference

12 December 2020

Lobucavir is phosphorylated in human cytomegalovirus-infected and -uninfected cells and inhibits the viral DNA polymerase

1 reference

12 December 2020

The safety and efficacy of adefovir dipivoxil, a novel anti-human immunodeficiency virus (HIV) therapy, in HIV-infected adults: a randomized, double-blind, placebo-controlled trial

1 reference

12 December 2020

Convenient twice daily foscarnet in induction therapy of AIDS-associated cytomegalovirus retinitis. The Foscarnet Italian Study Group

1 reference

12 December 2020

Treatment of cytomegalovirus retinopathy with ganciclovir

1 reference

12 December 2020

Efficacy and tolerance of intravitreal ganciclovir in cytomegalovirus retinitis in acquired immune deficiency syndrome

1 reference

12 December 2020

Vulval ulceration associated with foscarnet

1 reference

12 December 2020

Foscarnet-Induced Hypocalcemia and Effects of Foscarnet on Calcium Metabolism*

1 reference

12 December 2020

Intravitreal cidofovir for the maintenance treatment of cytomegalovirus retinitis

1 reference

12 December 2020

Mortality in patients with the acquired immunodeficiency syndrome treated with either foscarnet or ganciclovir for cytomegalovirus retinitis

1 reference

12 December 2020

Pharmacokinetic, safety, and antiviral profiles of oral ganciclovir in persons infected with human immunodeficiency virus: a phase I/II study. AIDS Clinical Trials Group, and Cytomegalovirus Cooperative Study Group

1 reference

12 December 2020

Nephrogenic diabetes insipidus associated with foscarnet treatment of cytomegalovirus retinitis

1 reference

12 December 2020

Randomized prospective trial of ganciclovir maintenance therapy for cytomegalovirus retinitis

1 reference

12 December 2020

Intraocular pressure and aqueous humor dynamics in patients with AIDS treated with intravitreal cidofovir (HPMPC) for cytomegalovirus retinitis

1 reference

12 December 2020

Central venous line infections in AIDS.

1 reference

12 December 2020

Severe hypocalcaemia in AIDS patients treated with foscarnet and pentamidine

1 reference

12 December 2020

Anti-human immunodeficiency virus (HIV) activity, safety, and pharmacokinetics of adefovir dipivoxil (9-[2-(bis-pivaloyloxymethyl)-phosphonylmethoxyethyl]adenine) in HIV-infected patients

1 reference

12 December 2020

Foscarnet and penile ulceration

1 reference

12 December 2020

Parenteral cidofovir for cytomegalovirus retinitis in patients with AIDS: the HPMPC peripheral cytomegalovirus retinitis trial. A randomized, controlled trial. Studies of Ocular complications of AIDS Research Group in Collaboration with the AIDS Cli

1 reference

12 December 2020

Foscarnet-induced penile ulcer

1 reference

12 December 2020

Foscarnet treatment of cytomegalovirus retinitis in patients with the acquired immunodeficiency syndrome

1 reference

12 December 2020

Low milk IgA antibody to Haemophilus influenzae colonising nasopharynx of infants

1 reference

12 December 2020

Retinal Detachments in Patients With Cytomegalovirus Retinitis

1 reference

12 December 2020

Intravitreal cidofovir (HPMPC) treatment of cytomegalovirus retinitis in patients with acquired immune deficiency syndrome.

1 reference

12 December 2020

Risk factors for development of rhegmatogenous retinal detachment in patients with cytomegalovirus retinitis.

1 reference

12 December 2020

Cytomegalovirus retinitis and response to therapy with ganciclovir

1 reference

12 December 2020

Foscarnet-induced penile ulcer in an uncircumcised patient with AIDS

1 reference

12 December 2020

Foscarnet therapy for ganciclovir-resistant cytomegalovirus retinitis in patients with AIDS.

1 reference

12 December 2020

Foscarnet-induced severe hypomagnesemia and other electrolyte disorders

1 reference

12 December 2020

Foscarnet therapy of cytomegalovirus retinitis in AIDS.

1 reference

12 December 2020

Treatment of cytomegalovirus retinitis with a sustained-release ganciclovir implant. The Ganciclovir Implant Study Group

1 reference

12 December 2020

Intravitreal and systemic foscarnet in the treatment of AIDS-related CMV retinitis

1 reference

12 December 2020

Cytomegalovirus retinitis: decreased risk of bilaterality with increased use of systemic treatment. Swiss HIV Cohort Study Group

1 reference

12 December 2020

Treatment of cytomegalovirus retinitis in AIDS patients using intravitreal injections of highly concentrated ganciclovir

1 reference

12 December 2020

Randomized phase I trial of two different combination foscarnet and ganciclovir chronic maintenance therapy regimens for AIDS patients with cytomegalovirus retinitis: AIDS clinical Trials Group Protocol 151

1 reference

12 December 2020

Indwelling central venous catheter infections in patients with acquired immune deficiency syndrome

1 reference

12 December 2020

Intravenous versus oral ganciclovir: European/Australian comparative study of efficacy and safety in the prevention of cytomegalovirus retinitis recurrence in patients with AIDS. The Oral Ganciclovir European and Australian Cooperative Study Group

1 reference

12 December 2020

Risk of developing cytomegalovirus retinitis in persons infected with the human immunodeficiency virus

1 reference

12 December 2020

Intravitreal foscarnet for cytomegalovirus retinitis in a patient with acquired immunodeficiency syndrome

1 reference

12 December 2020

Use of intravitreal ganciclovir (dihydroxy propoxymethyl guanine) for cytomegalovirus retinitis in a patient with AIDS.

1 reference

12 December 2020

2.5 years survival with sequential ganciclovir/foscarnet treatment in a patient with acquired immune deficiency syndrome and cytomegalovirus retinitis

1 reference

12 December 2020

Experience with central venous catheters in patients with AIDS

1 reference

12 December 2020

10.2165/00002018-199921030-00005

Identifiers

DOI

1 reference

Dimensions Publication ID

29 July 2017

1024563308

0 references

1 reference